Melanotan-I
Afamelanotide, MT-I, [Nle4-D-Phe7]-α-MSH, Scenesse, CUV-1647
A synthetic analog of alpha-melanocyte-stimulating hormone that stimulates melanogenesis, increasing skin pigmentation and providing photoprotection against UV radiation.
Completed
NCT01431326
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Daniel Benjamin
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT00346216
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT03793166
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT00490139
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Novartis Pharmaceuticals
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT01274338
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT05099640
A Study of PTC923 in Participants With Phenylketonuria
PTC Therapeutics
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT03595553
Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Summit Therapeutics
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT01925612
Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)
Seagen Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03379675
A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus
Janssen Research & Development, LLC
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00460811
Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Ironwood Pharmaceuticals, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT00617032
Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94
Targeted Genetics Corporation
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT02466555
Music Therapy in Sickle Cell Transition Study
University Hospitals Cleveland Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT05159778
Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)
HiberCell, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT06318650
Post Extraction Changes After Ridge Preservation Using Allogeneic Dentin Matrix Vs Demineralized Freeze Dried Allograft
Cairo University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT00006734
Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
Children's Oncology Group
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT00662909
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
Astellas Pharma Inc
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT07017998
External Therapy for Tinnitus Management
Restorear Devices LLC
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE3
NCT04701411
A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease
Takeda
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT03237234
Enhancing Corticospinal Activation for Improved Walking Function
Shepherd Center, Atlanta GA
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT06552793
Post Extraction Alterations Following Ridge Preservation In The Esthetic Zone Using Partially Demineralized Autogenous Dentine Graft Versus Xenograft
Cairo University
INTERVENTIONAL
Updated Dec 15, 2025